|
SGP SpyGlass Pharma Inc 1778922 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-13,818,000.00 |
| Balance Sheet |
|
Current Assets
|
$253,362,000.00 |
|
Assets
|
$258,386,000.00 |
|
Current Liabilities
|
$6,667,000.00 |
|
Liabilities
|
$8,274,000.00 |
|
Equity
|
$250,112,000.00 |
|
Shares Out
|
33432555.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-13,544,000.00 |
|
Investing Cash Flow
|
$-1,667,000.00 |
| Market Analysis |
Market Cap
|
$759,587,649.60 |
|
Price
|
$22.95 |
|
BVPS
|
7.48 |
|
PB
|
3.04 |
|
EPS
|
-0.69 |
|
FCF
|
$-14,220,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:28 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:24 |
|
| Apr |
May |
Jun |
|
|
|
|
2026-05-14 |
-0.69 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view SGP documents filed with the SEC.
SGP Filings
Clear
